机构:[1]Department of Pharmacognosy, West China School of Pharmacy, Sichuan University, Chengdu 610041, China[2]National Key Laboratory of Drug Regulatory Science, National Medical Products Administration (NMPA), Beijing 100038, China[3]Chongqing Key Laboratory of Child Infection and Immunity, Children’s Hospital of Chongqing Medical University, Chongqing 400014, China[4]Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Academy of Chinese Medicine Sciences, Sichuan Institute for Translational Chinese Medicine, Chengdu, Sichuan 610041, China
The Project of Sichuan
Provincial Administration of Traditional Chinese Medicine
(2020YSHB01) and Major Scientific and Technological Projects of
Sichuan Provincial Administration of Traditional Chinese Medicine
(2021XYCZ001).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|4 区医学
小类|4 区病毒学
最新[2023]版:
大类|4 区医学
小类|4 区病毒学
第一作者:
第一作者机构:[1]Department of Pharmacognosy, West China School of Pharmacy, Sichuan University, Chengdu 610041, China
通讯作者:
通讯机构:[1]Department of Pharmacognosy, West China School of Pharmacy, Sichuan University, Chengdu 610041, China[2]National Key Laboratory of Drug Regulatory Science, National Medical Products Administration (NMPA), Beijing 100038, China[*1]Department of Pharmacognosy, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
推荐引用方式(GB/T 7714):
Li Jinhua,Zhao Yao,Dai Ying,et al.Identification of γ-Fagarine as a novel antiviral agent against respiratory virus (hMPV) infection[J].Virus research.2023,336:199223.doi:10.1016/j.virusres.2023.199223.
APA:
Li Jinhua,Zhao Yao,Dai Ying&Zhao Junning.(2023).Identification of γ-Fagarine as a novel antiviral agent against respiratory virus (hMPV) infection.Virus research,336,
MLA:
Li Jinhua,et al."Identification of γ-Fagarine as a novel antiviral agent against respiratory virus (hMPV) infection".Virus research 336.(2023):199223